Comparison Chart Myriad Genetics, Inc.

Stocks

MYGN

US62855J1043

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq 16:00:00 2026-10-23 EDT			5-day change	1st Jan Change
5.820 ^USD	+1.04%		+46.23%	-5.37%

10-22	Myriad Genetics Says New Results Show Potential of MRD Detection in Colorectal, Pancreatic Cancers	MT
10-22	Myriad Genetics, Inc. Releases New MONSTAR-SCREEN-3 Data Demonstrating The Potential Of Ultra-Sensitive MRD Detection In Colorectal And Pancreatic Cancers	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Compared values

		Sector	Change	5-day change	YTD change	1-year change	5-year change	Capi.	ST	MT	LT
	MYRIAD GENETICS, INC.	Diagnostic & Testing Substances	+1.04%	+46.23%	-5.37%	-27.70%	-82.07%	557M